131 related articles for article (PubMed ID: 9009155)
1. Breast-cancer mortality in a non-randomized trial on mammographic screening in women over age 65.
Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
Int J Cancer; 1997 Jan; 70(2):164-8. PubMed ID: 9009155
[TBL] [Abstract][Full Text] [Related]
2. Effect on breast cancer mortality of biennial mammographic screening of women under age 50.
Peer PG; Werre JM; Mravunac M; Hendriks JH; Holland R; Verbeek AL
Int J Cancer; 1995 Mar; 60(6):808-11. PubMed ID: 7896450
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.
van Dijck JA; Holland R; Verbeek AL; Hendriks JH; Mravunac M
J Natl Cancer Inst; 1994 Jun; 86(12):934-8. PubMed ID: 8196083
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme.
Peeters PH; Verbeek AL; Straatman H; Holland R; Hendriks JH; Mravunac M; Rothengatter C; Van Dijk-Milatz A; Werre JM
Int J Epidemiol; 1989 Jun; 18(2):295-9. PubMed ID: 2788627
[TBL] [Abstract][Full Text] [Related]
5. Repeated mammographic screening reduces breast cancer mortality along the continuum of age.
Broeders MJ; Verbeek AL; Straatman H; Peer PG; Jong PC; Beex LV; Hendriks JH; Holland R
J Med Screen; 2002; 9(4):163-7. PubMed ID: 12518006
[TBL] [Abstract][Full Text] [Related]
6. Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997.
Broeders MJ; Peer PG; Straatman H; Beex LV; Hendriks JH; Holland R; Verbeek AL
Int J Cancer; 2001 Apr; 92(2):303-8. PubMed ID: 11291061
[TBL] [Abstract][Full Text] [Related]
7. Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.
Van Dijck JA; Verbeek AL; Beex LV; Hendriks JH; Holland R; Mravunac M; Straatman H; Werre JM
Int J Cancer; 1996 Jun; 66(6):727-31. PubMed ID: 8647640
[TBL] [Abstract][Full Text] [Related]
8. The relative effect of mammographic screening on breast cancer mortality by socioeconomic status.
Ripping TM; van der Waal D; Verbeek ALM; Broeders MJM
Medicine (Baltimore); 2016 Aug; 95(31):e4335. PubMed ID: 27495038
[TBL] [Abstract][Full Text] [Related]
9. Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
van Dijck J; Verbeek A; Hendriks J; Holland R; Mravunac M
Br J Cancer; 1996 Dec; 74(11):1838-42. PubMed ID: 8956803
[TBL] [Abstract][Full Text] [Related]
10. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.
Andersson I; Aspegren K; Janzon L; Landberg T; Lindholm K; Linell F; Ljungberg O; Ranstam J; Sigfússon B
BMJ; 1988 Oct; 297(6654):943-8. PubMed ID: 3142562
[TBL] [Abstract][Full Text] [Related]
11. Effective biennial mammographic screening in women aged 40-49.
van Schoor G; Moss SM; Otten JD; Donders R; Paap E; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
Eur J Cancer; 2010 Dec; 46(18):3137-40. PubMed ID: 21036034
[TBL] [Abstract][Full Text] [Related]
12. Mammographic breast density and risk of breast cancer: masking bias or causality?
van Gils CH; Otten JD; Verbeek AL; Hendriks JH
Eur J Epidemiol; 1998 Jun; 14(4):315-20. PubMed ID: 9690746
[TBL] [Abstract][Full Text] [Related]
13. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
14. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
15. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
Jonsson H; Nyström L; Törnberg S; Lenner P
J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
[TBL] [Abstract][Full Text] [Related]
16. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
[TBL] [Abstract][Full Text] [Related]
17. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
Moss S
J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
[TBL] [Abstract][Full Text] [Related]
18. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer among women over 75 years: an important public health problem?
van Schoor G; Otten JD; den Heeten GJ; Holland R; Broeders MJ; Verbeek AL
Eur J Public Health; 2012 Jun; 22(3):422-4. PubMed ID: 22271761
[TBL] [Abstract][Full Text] [Related]
20. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country.
Lee M; Mariapun S; Rajaram N; Teo SH; Yip CH
BMC Public Health; 2017 Jan; 17(1):127. PubMed ID: 28129762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
